2 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Multiple Myeloma Progression: new trials by email Literature Review of Multiple Myeloma Progression trials Research Report on Multiple Myeloma Progression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma Rivaroxaban, ASA - Multiple Myeloma in Relapse, Multiple Myeloma Progression | Phase 2 / Phase 3 | Unknown | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 57 | 2019-01-17 | 2024-02-29 |
| Pomalidomide/Cyclophosphamide/Dexamethasone in Relapse Refractory Myeloma: Safety Profile in Mexicans Pomalidomide - Multiple Myeloma in Relapse, Multiple Myeloma Progression | Phase 2 | Unknown | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | 18 | 2018-09-01 | 2018-11-14 |
Multiple Myeloma (2) · Disease Progression (1) · Recurrence (1)
Blood Protein Disorders (2) · Cardiovascular Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Plasma Cell (2) · Paraproteinemias (2) · Vascular Diseases (2) · Disease Attributes (1)
Aspirin (1) · Cyclophosphamide (1) · Dexamethasone (1) · Rivaroxaban (1) · pomalidomide (1)
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)
Canada (1) · Mexico (1)
PMID 15189396, PMID 15842354, PMID 18094721, PMID 20637084, PMID 22409262, PMID 23903204, PMID 26986753, PMID 34582035